Ronald Domalaon

1.4k total citations · 1 hit paper
23 papers, 1.1k citations indexed

About

Ronald Domalaon is a scholar working on Molecular Medicine, Molecular Biology and Microbiology. According to data from OpenAlex, Ronald Domalaon has authored 23 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Medicine, 12 papers in Molecular Biology and 11 papers in Microbiology. Recurrent topics in Ronald Domalaon's work include Antibiotic Resistance in Bacteria (18 papers), Antimicrobial Peptides and Activities (11 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Ronald Domalaon is often cited by papers focused on Antibiotic Resistance in Bacteria (18 papers), Antimicrobial Peptides and Activities (11 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Ronald Domalaon collaborates with scholars based in Canada, China and France. Ronald Domalaon's co-authors include Frank Schweizer, George G. Zhanel, Temilolu Idowu, Xuan Yang, Yinfeng Lyu, Bala Kishan Gorityala, Ayush Kumar, Andrew Walkty, Sheryl Zelenitsky and Joseph P. Lynch and has published in prestigious journals such as Clinical Microbiology Reviews, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Ronald Domalaon

23 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli

2019 311 citations George G. Zhanel, Alyssa Golden et al. Drugs profile →

Peers

Countries citing papers authored by Ronald Domalaon

Since Specialization

Citations

This map shows the geographic impact of Ronald Domalaon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald Domalaon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald Domalaon more than expected).

Fields of papers citing papers by Ronald Domalaon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald Domalaon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald Domalaon. The network helps show where Ronald Domalaon may publish in the future.

Co-authorship network of co-authors of Ronald Domalaon

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald Domalaon. A scholar is included among the top collaborators of Ronald Domalaon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald Domalaon. Ronald Domalaon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Exploring Structure–Activity Relationships of Niclosamide-Based Colistin Potentiators in Colistin-Resistant Gram-Negative Bacteria 2024 ·Antibiotics ·(unknown), (unknown), (unknown), (unknown), (unknown), Ronald Domalaon, Gilbert Arthur, Frank Schweizer	3
2	Sulfonamide Bioisosteres of Niclosamide Enhance Antibacterial Activity of Colistin and Bacitracin 2024 ·ChemMedChem ·(unknown), (unknown), Ronald Domalaon, Frank Schweizer	1
3	Dioctanoyl Ultrashort Tetrabasic β-Peptides Sensitize Multidrug-Resistant Gram-Negative Bacteria to Novobiocin and Rifampicin 2021 ·Frontiers in Microbiology ·(unknown), (unknown), Ronald Domalaon, Yanqi Li, Gilbert Arthur, Ayush Kumar, Frank Schweizer	6
4	Dilipid Ultrashort Tetrabasic Peptidomimetics Potentiate Novobiocin and Rifampicin Against Multidrug-Resistant Gram-Negative Bacteria 2020 ·ACS Infectious Diseases ·(unknown), (unknown), Ronald Domalaon, (unknown), Frank Schweizer	30
5	Amphiphilic nebramine-based hybrids Rescue legacy antibiotics from intrinsic resistance in multidrug-resistant Gram-negative bacilli 2019 ·European Journal of Medicinal Chemistry ·Xuan Yang, (unknown), Temilolu Idowu, Ronald Domalaon, (unknown), (unknown), Liting Bi, (unknown), George G. Zhanel, Ayush Kumar, Frank Schweizer	17
6	Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli breakdown → 2019 ·Drugs ·George G. Zhanel, Alyssa Golden, Sheryl Zelenitsky, (unknown), Courtney K. Lawrence, Heather J. Adam, Temilolu Idowu, Ronald Domalaon, Frank Schweizer, Michael A. Zhanel, Philippe Lagacé‐Wiens, Andrew Walkty, Ayman Noreddin, Joseph P. Lynch, James A. Karlowsky	311
7	Synergistic combinations of anthelmintic salicylanilides oxyclozanide, rafoxanide, and closantel with colistin eradicates multidrug-resistant colistin-resistant Gram-negative bacilli 2019 ·The Journal of Antibiotics ·Ronald Domalaon, (unknown), George G. Zhanel, Frank Schweizer	35
8	Repurposed Antimicrobial Combination Therapy: Tobramycin-Ciprofloxacin Hybrid Augments Activity of the Anticancer Drug Mitomycin C Against Multidrug-Resistant Gram-Negative Bacteria 2019 ·Frontiers in Microbiology ·Ronald Domalaon, (unknown), (unknown), Bala Kishan Gorityala, George G. Zhanel, Frank Schweizer	42
9	The Anthelmintic Drug Niclosamide Synergizes with Colistin and Reverses Colistin Resistance in Gram-Negative Bacilli 2019 ·Antimicrobial Agents and Chemotherapy ·Ronald Domalaon, (unknown), Ayush Kumar, George G. Zhanel, Frank Schweizer	61
10	Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens? 2018 ·Clinical Microbiology Reviews ·Ronald Domalaon, Temilolu Idowu, George G. Zhanel, Frank Schweizer	219
11	Development of dilipid polymyxins: Investigation on the effect of hydrophobicity through its fatty acyl component 2018 ·Bioorganic Chemistry ·Ronald Domalaon, (unknown), (unknown), George G. Zhanel, Frank Schweizer	18
12	Tobramycin-Linked Efflux Pump Inhibitor Conjugates Synergize Fluoroquinolones, Rifampicin and Fosfomycin against Multidrug-Resistant Pseudomonas aeruginosa 2018 ·Journal of Clinical Medicine ·Xuan Yang, Ronald Domalaon, Yinfeng Lyu, George G. Zhanel, Frank Schweizer	24
13	Dilipid ultrashort cationic lipopeptides as adjuvants for chloramphenicol and other conventional antibiotics against Gram-negative bacteria 2018 ·Amino Acids ·Ronald Domalaon, (unknown), (unknown), Brandon Findlay, George G. Zhanel, Frank Schweizer	20
14	Absolute Quantitation of Glycoforms of Two Human IgG Subclasses Using Synthetic Fc Peptides and Glycopeptides 2018 ·Journal of the American Society for Mass Spectrometry ·(unknown), (unknown), (unknown), Ronald Domalaon, (unknown), Jean Harb, Sylvie Hermouet, Oleg V. Krokhin, Frank Schweizer, Hélène Perreault	15
15	Amphiphilic Tobramycin–Lysine Conjugates Sensitize Multidrug Resistant Gram-Negative Bacteria to Rifampicin and Minocycline 2017 ·Journal of Medicinal Chemistry ·Yinfeng Lyu, Xuan Yang, Sudeep Goswami, Bala Kishan Gorityala, Temilolu Idowu, Ronald Domalaon, George G. Zhanel, Anshan Shan, Frank Schweizer	76
16	A Tobramycin Vector Enhances Synergy and Efficacy of Efflux Pump Inhibitors against Multidrug-Resistant Gram-Negative Bacteria 2017 ·Journal of Medicinal Chemistry ·Xuan Yang, Sudeep Goswami, Bala Kishan Gorityala, Ronald Domalaon, Yinfeng Lyu, Ayush Kumar, George G. Zhanel, Frank Schweizer	59
17	Amphiphilic lysine conjugated to tobramycin synergizes legacy antibiotics against wild‐type and multidrug‐resistant Pseudomonas aeruginosa 2017 ·Peptide Science ·Yinfeng Lyu, Ronald Domalaon, Xuan Yang, Frank Schweizer	21
18	Ultrashort cationic lipopeptides and lipopeptoids: Evaluation and mechanistic insights against epithelial cancer cells 2016 ·Peptides ·Ronald Domalaon, Brandon Findlay, (unknown), Gilbert Arthur, Frank Schweizer	32
19	Short Antimicrobial Peptides and Peptide Scaffolds as Promising Antibacterial Agents 2016 ·Current Topics in Medicinal Chemistry ·Ronald Domalaon, George G. Zhanel, Frank Schweizer	45
20	Structure–activity relationships in ultrashort cationic lipopeptides: the effects of amino acid ring constraint on antibacterial activity 2014 ·Amino Acids ·Ronald Domalaon, Xuan Yang, Joe D. O’Neil, George G. Zhanel, Neeloffer Mookherjee, Frank Schweizer	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact